
Motivi Pharmaceuticals Private Limited
About Motivi Pharmaceuticals Private Limited
Data last updated:
Motivi Pharmaceuticals Private Limited is a private limited company based in Colvale, Goa, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U51909GA2014PTC007454. Its GSTIN is 30AAJCM2327E1Z0 (Goa). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Oscar Kyriel Dsouza and Vikram Naharwar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot S – 12 Near Sharayu Toyota Colvale Industrial Estate, Goa, India – 403513.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.53 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net loss of ₹2.2 Lakh (net margin -11.9%) and EBITDA of -₹1.81 Lakh (EBITDA margin -9.8%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Motivi Pharmaceuticals Private Limited's registered office is in Colvale, Goa. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot S – 12 Near Sharayu Toyota Colvale Industrial Estate, Goa, India – 403513
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Motivi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Motivi Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Motivi Pharmaceuticals Private Limited, buy the company report.
Financials of Motivi Pharmaceuticals Private Limited
FY 2025 filings availableMotivi Pharmaceuticals Private Limited reported revenue of ₹18.53 Lakh (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 17% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 13%. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.8% | ||||
| Net Profit Margin | -11.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Motivi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Motivi Pharmaceuticals Private Limited
Motivi Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Oscar Kyriel Dsouza | Director | 16 Sep 2014 | 12 Years 1 Months | Current |
| Vikram Naharwar | Director | 25 Mar 2014 | 12 Years 7 Months | Current |
Auditor
Motivi Pharmaceuticals Private Limited is audited by SUHAS MANNUR & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUHAS MANNUR & CO | FY 2019 | 122428W |
Shareholding
The shareholding of Motivi Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Motivi Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Motivi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Motivi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Motivi Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 30AAJCM2327E1Z0 | Goa | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Motivi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Motivi Pharmaceuticals Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Yulia Nasypayko ceased to be Director on 09 May 2022.
Frequently asked questions
Motivi Pharmaceuticals is an active private limited company based in Colvale, Goa, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 March 2014 (12+ years old) and is registered under CIN U51909GA2014PTC007454.
Motivi Pharmaceuticals has 2 current directors:
- Oscar Kyriel Dsouza - Director
- Vikram Naharwar - Director
The latest financial statements of Motivi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Motivi Pharmaceuticals is 30AAJCM2327E1Z0, registered in Goa. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Motivi Pharmaceuticals is U51909GA2014PTC007454. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Motivi Pharmaceuticals was incorporated on 25 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Goa.
Yulia Nasypayko ceased to be Director on 09 May 2022. Anil Motihar ceased to be Director on 16 Sep 2014. Oscar Kyriel Dsouza was appointed as Director on 16 Sep 2014. Motivi Pharmaceuticals has 4 board changes on record in total.
The registered office of Motivi Pharmaceuticals is at Plot S – 12 Near Sharayu Toyota Colvale Industrial Estate, Goa, India – 403513.
Motivi Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Motivi Pharmaceuticals is compliant as of 23 July 2026. The company is actively filing with the Registrar of Companies.

